Annual report pursuant to Section 13 and 15(d)

Related Party Transactions (Narrative) (Details)

v3.19.3.a.u2
Related Party Transactions (Narrative) (Details) - Chief Scientific Officer [Member] - USD ($)
12 Months Ended
Sep. 30, 2019
Sep. 30, 2018
Related Party Transaction [Line Items]    
Ownership interest 25.00%  
Aspen Park Pharmaceuticals, Inc. (APP) [Member]    
Related Party Transaction [Line Items]    
Related party transactions, amount $ 0 $ 0